A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Stopped It is planned to restart the clinical study after the completion of the clinical trial protocol modification.

Conditions

• Tuberculosis

Interventions

• BIOLOGICAL: Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
• BIOLOGICAL: High-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
• BIOLOGICAL: High-dose adjuvant for freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
• BIOLOGICAL: Lyophilized recombinant tuberculosis vaccine (AEC / BC02) placebo

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.